|
With more than 30 years of diverse experience in the healthcare industry, ranging from diagnostics and devices to pharmaceuticals, Mr. Garner has been involved in the creation, development or management of a number of important healthcare companies. He was part of the senior management team that built Hybritech, Inc., and Chairman and CEO of Dura Pharmaceuticals, Inc., which grew from a $2 million to a $300 million company under his leadership, which ended in November of 2000 when the company was sold to Elan Corporation, plc for $1.8 billion.
Mr. Garner recently formed specialty pharmaceutical companies Verus Pharmaceuticals, Inc. and Cadence Pharmaceuticals, Inc. Mr. Garner serves as Chairman and CEO of Verus and Chairman of Cadence. In 1998, Mr. Garner founded and served as Chairman of DJ Pharma, which was sold to Biovail in 2000 for over $200 million. In 2001, he founded and served as Chairman of Xcel Pharmaceuticals, which was sold to Valeant in 2005 for $280 million. Currently, he also serves on the board of numerous companies, including Pharmion Corporation, Somaxon Pharmaceuticals, Inc., SkinMedica, Inc., and Aegis Therapeutics, LLC; as well as on the board of several charitable organizations | 